Type 1 Diabetes Can Look Different in Adults—Even When Someone Is Overweight

For decades, type 1 diabetes has been thought of as a disease of children and young, lean people. Type 2 diabetes, by contrast, is often associated with adults and obesity. But this picture is increasingly incomplete. A case reported in medical literature describes a 51-year-old man with obesity who developed severe, sudden-onset autoimmune type 1 diabetes—challenging the idea that age and body weight can reliably determine diabetes type.

This case underscores a growing recognition in medicine: type 1 diabetes in adults can present with features that overlap with type 2 diabetes, making diagnosis harder if doctors rely solely on appearance or age.

The 51-year-old patient arrived at the hospital in diabetic ketoacidosis (DKA), a life-threatening condition in which the body produces too many ketones and becomes dangerously acidic. His blood glucose was extremely elevated at 1,297 mg/dL, and his bicarbonate level was critically low at 7 mmol/L.

Testing revealed he had strong antibodies against glutamic acid decarboxylase (GAD)—a marker of autoimmune type 1 diabetes. His C-peptide level was very low, confirming that his pancreas was producing almost no insulin. Despite his obesity, he had the immunological hallmark of type 1 diabetes: the body's immune system was attacking insulin-producing cells.

If this patient had been assumed to have type 2 diabetes based on his age and weight alone, he would likely have been started on different medications—ones that work by increasing insulin sensitivity or reducing blood sugar, rather than replacing insulin. That delay could have made his condition worse.

With proper diagnosis, he was treated with insulin therapy and improved with standard DKA management. His case demonstrates why accurate identification of diabetes type is critical: it directly determines the right treatment and can prevent serious complications.

The medical team emphasizes that when someone develops diabetes suddenly with severe insulin deficiency, testing for islet autoantibodies and C-peptide levels should not be skipped—even in adults, even in people with obesity. These tests provide clear answers about whether type 1 diabetes is the cause.

Age and body habitus alone are not reliable guides to diabetes type. Early recognition through antibody testing and assessment of remaining insulin production is essential to guide therapy and prevent recurrent metabolic crises. For anyone diagnosed with diabetes in adulthood, asking for autoantibody testing can provide clarity and ensure the right treatment plan from the start.

Source: Proceedings (Baylor University. Medical Center). Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.